{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T05:49:04Z","timestamp":1724910544839},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Psychological disorders, such as depression and anxiety, are known to be associated with chronic heart failure (CHF). The present study was conducted to evaluate the effect of mental status on quality of life (QoL) in metoprolol treated CHF patients with depression, anxiety, and burn-out.<\/jats:p>\n            <jats:p>This single-center prospective study was conducted between February 2013 and April 2016, enrolled CHF patients (resting heart rate &gt;80 bpm) with depression, anxiety, and burn out at baseline. Hospital anxiety and depression scale (HADS) and Copenhagen burnout inventory (CBI) were used to assess the depression\u2013anxiety status and burn-out status, respectively. Change in QoL was evaluated as the endpoint at 1st, 3rd, 6th, and 12th month from baseline using Minnesota Living with Heart Failure Questionnaire (MLHFQ) and short form-8 (SF-8) scales. A student <jats:italic toggle=\"yes\">t<\/jats:italic> test was used to determine the change and <jats:italic toggle=\"yes\">P<\/jats:italic> value\u200a&lt;\u200a.05 was considered statistically significant. One hundred fifty-four patients were enrolled (median age 66 years; 65.58% males) and divided into 8 groups based on the HADS and CBI scores at baseline. Overall, the mean SF8 score and MLHFQ scores in different mental status groups showed a significant improvement (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05) in QoL from baseline to 12th month, with no significant difference reported between the groups. With regard to the follow-up periods, there was a deterioration in QoL until 3rd month, after which there was a significant improvement (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05).<\/jats:p>\n            <jats:p>There was a significant improvement in QoL in metoprolol treated CHF patients with depression, anxiety, and burn-out.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014252","type":"journal-article","created":{"date-parts":[[2019,1,25]],"date-time":"2019-01-25T07:15:32Z","timestamp":1548400532000},"page":"e14252","source":"Crossref","is-referenced-by-count":3,"title":["Improvement in quality of life of Chinese chronic heart failure patients with neuropsychiatric complications over 12-months post-treatment with metoprolol"],"prefix":"10.1097","volume":"98","author":[{"given":"Ran","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","article-title":"Adrenergic nervous system in heart failure: pathophysiology and therapy","volume":"113","author":"Lymperopoulos","year":"2013","journal-title":"Circ Res"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","year":"2010","journal-title":"J Card Fail"},{"key":"R4-20230914","first-page":"98","article-title":"Chinese guidelines for the diagnosis and treatment of heart failure 2014","volume":"42","year":"2014","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","article-title":"Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes","volume":"48","author":"Rutledge","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R6-20230914","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/JCN.0000000000000265","article-title":"Prevalence and measurement of anxiety in samples of patients with heart failure: meta-analysis","volume":"31","author":"Easton","year":"2016","journal-title":"J Cardiovasc Nurs"},{"key":"R7-20230914","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/gps.2463","article-title":"Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles","volume":"25","author":"Yohannes","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1015761618314","article-title":"Acute delirium induced by metoprolol","volume":"16","author":"Fisher","year":"2002","journal-title":"Cardiovasc Drugs Ther"},{"key":"R9-20230914","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1752-1947-6-65","article-title":"Metoprolol-induced visual hallucinations: a case series","volume":"6","author":"Goldner","year":"2012","journal-title":"J Med Case Reports"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1345\/aph.17185","article-title":"Beta-blockers and depression: the more the murkier?","volume":"32","author":"Ried","year":"1998","journal-title":"Ann Pharmacother"},{"key":"R11-20230914","doi-asserted-by":"crossref","DOI":"10.1016\/j.genhosppsych.2010.04.008","article-title":"Sleep disorders, nightmares, depression and anxiety in an elderly patient treated with low-dose metoprolol","volume":"32","author":"Ahmed","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"key":"R12-20230914","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2044.1990.tb14502.x","article-title":"Effect of metoprolol and diazepam on pre-operative anxiety","volume":"45","author":"Jakobsen","year":"1990","journal-title":"Anaesthesia"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2015.11.018","article-title":"Initiation of (-blocker therapy and depression after acute myocardial infarction","volume":"174","author":"Ranchord","year":"2016","journal-title":"Am Heart J"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1053\/euhj.2002.3255","article-title":"Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population","volume":"23","author":"Hobbs","year":"2002","journal-title":"Eur Heart J"},{"key":"R15-20230914","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cardfail.2004.11.004","article-title":"Effect of valsartan on quality of life when added to usual therapy for heart failure: results from the Valsartan Heart Failure Trial","volume":"11","author":"Majani","year":"2005","journal-title":"J Card Fail"},{"key":"R16-20230914","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"R17-20230914","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.cardfail.2009.05.003","article-title":"Improvement in health-related quality of life after hospitalization predicts event-free survival in patients with advanced heart failure","volume":"15","author":"Moser","year":"2009","journal-title":"J Card Fail"},{"key":"R18-20230914","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.clinbiochem.2010.09.007","article-title":"Post-discharge changes in NT-proBNP and quality of life after acute dyspnea hospitalization as predictors of one-year outcomes","volume":"43","author":"Shah","year":"2010","journal-title":"Clin Biochem"},{"key":"R20-20230914","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/bmj.292.6534.1491","article-title":"Quality of life after myocardial infarction: effect of long term metoprolol on mortality and morbidity","volume":"292","author":"Olsson","year":"1986","journal-title":"Br Med J Clin Res Ed"},{"key":"R21-20230914","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1540-8167.2009.01518.x","article-title":"Effect of metoprolol on quality of life in the prevention of Syncope Trial","volume":"20","author":"Sheldon","year":"2009","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R22-20230914","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02627961","article-title":"Quality of life on treatment with metoprolol in dilated cardiomyopathy: results from the MDC trial. Metoprolol in Dilated Cardiomyopathy trial","volume":"10","author":"Wiklund","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"key":"R23-20230914","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ahj.2012.08.015","article-title":"Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study","volume":"164","author":"Bhardwaj","year":"2012","journal-title":"Am Heart J"},{"key":"R24-20230914","doi-asserted-by":"crossref","first-page":"24","DOI":"10.20996\/1819-6446-2007-3-5-24-30","article-title":"Effects of beta-blocker metoprolol on quality of life in elderly patients with chronic heart failure","volume":"3","author":"Vologdina","year":"2007","journal-title":"Ration Pharmacother Cardiol"},{"key":"R25-20230914","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/DDDT.S124497","article-title":"Impact of metoprolol treatment on mental status of chronic heart failure patients with neuropsychiatric disorders","volume":"11","author":"Liu","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"R26-20230914","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1253\/circj.CJ-15-0502","article-title":"Quality of life and influential factors in patients implanted with a left ventricular assist device","volume":"79","author":"Kato","year":"2015","journal-title":"Circ J"},{"key":"R27-20230914","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1477-7525-1-29","article-title":"The hospital anxiety and depression scale","volume":"1","author":"Snaith","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"R28-20230914","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/02678370500297720","article-title":"The Copenhagen Burnout Inventory: a new tool for the assessment of burnout","volume":"19","author":"Kristensen","year":"2005","journal-title":"Work Stress"},{"key":"R29-20230914","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.jacc.2011.03.072","article-title":"Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction","volume":"58","author":"Januzzi","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R30-20230914","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/j.1875-9114.1987.tb04029.x","article-title":"Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers","volume":"7","author":"Drayer","year":"1987","journal-title":"Pharmacotherapy"},{"key":"R31-20230914","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.cardfail.2005.03.006","article-title":"Depression and anxiety in heart failure","volume":"11","author":"Konstam","year":"2005","journal-title":"J Card Fail"},{"key":"R32-20230914","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-G","article-title":"Beta-blockers and central nervous system side effects","volume":"46","author":"McAinsh","year":"1990","journal-title":"Pharmacol Ther"},{"key":"R33-20230914","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/00005344-198904000-00020","article-title":"Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility","volume":"13","author":"Conant","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"R34-20230914","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/02813438909103664","article-title":"Quality of life in postmyocardial infarction patients in relation to drug therapy","volume":"7","author":"Wiklund","year":"1989","journal-title":"Scand J Prim Health Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T18:31:20Z","timestamp":1694716280000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201901250-00068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014252","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}